Xanadu Quantum Technologies Limited XNDU
2.38 USD -0.24 (-9.16%)
At closeNov 6, 2026, 6:53 AM EST
2.50 +0.12 +5.04%
Pre-market · Nov 6, 6:53 AM ET
2.34 Day range 2.60
2.34 52-week range 42.44
- YTD
- -70.29%
- 1 year
- -70.29%
Financial health
Altman Z-Score
0.49 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
Rating
C+2 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 3
- P/E 1
- P/B 5
Valuation
P/E -5.0×
FY 2023 5y median -82.1× FY 2025
P/S 76.3×
FY 2023 5y median 1362× FY 2025
P/B 1.2×
FY 2023 5y median 25.6× FY 2025
P/FCF -129×
FY 2023 5y median -84.5× FY 2025
EV/EBITDA -5.5×
FY 2023 5y median -89.8× FY 2025
EV/Sales 76.2×
FY 2023 5y median 1322× FY 2025
FCF Yield -0.8%
FY 2023 5y median -1.2% FY 2025
Profitability
Gross Margin 92.2%
FY 2023 5y median 75.6% FY 2025
Operating Margin -1501.5%
FY 2023 5y median -1682.0% FY 2025
Net Margin -1530.6%
FY 2023 5y median -1530.6% FY 2025
ROE -23.8%
FY 2023 5y median -27.0% FY 2025
ROIC -22.5%
FY 2023 5y median -28.0% FY 2025
ROA -22.7%
FY 2023 5y median -23.6% FY 2025
Growth (YoY)
Revenue 190.6%
FY 2023 FY 2025
Operating Income -37.0%
FY 2023 FY 2025
EPS (diluted) -1473.3%
FY 2023 FY 2025
Free Cash Flow 94.4%
FY 2023 FY 2025
Financial Health
Current Ratio 0.3×
FY 2023 5y median 16.8× FY 2025
Quick Ratio 0.3×
FY 2023 5y median 16.2× FY 2025
Debt / Equity 0.0×
FY 2023 5y median 0.1× FY 2025
Net Debt / EBITDA 0.0×
FY 2023 5y median 1.3× FY 2025
Interest Coverage 0.0×
FY 2023 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2023 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2023 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31